pmCIT-CFPGgVcl 1-419 control 2 FRET
(Plasmid
#46283)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 46283 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepmCitrine-C1
-
Backbone manufacturerCraig lab
- Total vector size (bp) 4700
-
Modifications to backbonelikely modified from pEYFP-C1
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameECFP + Vcl 1-419
-
Alt nameVinculin
-
Alt nameVcl
-
SpeciesG. gallus (chicken)
-
Mutationaa 1-419
-
Entrez GeneVCL (a.k.a. VINC1)
- Promoter CMV
-
Tag
/ Fusion Protein
- mCitrine (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (not destroyed)
- 3′ cloning site KpnI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer SV40pA-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Citrine proved to be a more stable FP in vivo than YFP; CIT was used to make a second generation vinculin FRET probe (first generation control is Addgene plasmid 46277).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pmCIT-CFPGgVcl 1-419 control 2 FRET was a gift from Susan Craig (Addgene plasmid # 46283 ; http://n2t.net/addgene:46283 ; RRID:Addgene_46283) -
For your References section:
Coincidence of actin filaments and talin is required to activate vinculin. Chen H, Choudhury DM, Craig SW. J Biol Chem. 2006 Dec 29;281(52):40389-98. Epub 2006 Oct 29. 10.1074/jbc.M607324200 PubMed 17074767